BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oduori OS, Murao N, Shimomura K, Takahashi H, Zhang Q, Dou H, Sakai S, Minami K, Chanclon B, Guida C, Kothegala L, Tolö J, Maejima Y, Yokoi N, Minami Y, Miki T, Rorsman P, Seino S. Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes. J Clin Invest 2020;130:6639-55. [PMID: 33196462 DOI: 10.1172/JCI140046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
Number Citing Articles
1 Accili D, Bell GI, Thorens B. Susumu Seino, MD, DMSci (1948–2021): A Pioneer in the Biology of Insulin Secretion. Diabetes 2022;71:2490-2495. [DOI: 10.2337/dbi22-0011] [Reference Citation Analysis]
2 Al-Zaid B, Chacko S, Ezeamuzie CI, Bünemann M, Krasel C, Karimian T, Lanzerstorfer P, Al-Sabah S. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells. Pharmacol Res Perspect 2022;10:e01013. [PMID: 36177761 DOI: 10.1002/prp2.1013] [Reference Citation Analysis]
3 Jones B, Burade V, Akalestou E, Manchanda Y, Ramchunder Z, Carrat G, Nguyen-Tu MS, Marchetti P, Piemonti L, Leclerc I, Rajamannar T, Vilsboll T, Thorens B, Tomas A, Rutter GA. In vivo and in vitro characterisation of GL0034, a novel long-acting GLP-1 receptor agonist. Diabetes Obes Metab 2022. [PMID: 35676825 DOI: 10.1111/dom.14794] [Reference Citation Analysis]
4 Zaborska KE, Jordan KL, Thorson AS, Dadi PK, Schaub CM, Nakhe AY, Dickerson MT, Lynch JC, Weiss AJ, Dobson JR, Jacobson DA. Liraglutide increases islet Ca2+ oscillation frequency and insulin secretion by activating hyperpolarization-activated cyclic nucleotide-gated channels. Diabetes Obes Metab 2022. [PMID: 35546791 DOI: 10.1111/dom.14747] [Reference Citation Analysis]
5 Yang Y, Lei T, Bi W, Xiao Z, Zhang X, Du H. The combined therapy of mesenchymal stem cell transplantation and resveratrol for diabetes: Future applications and challenges. Life Sci 2022;:120563. [PMID: 35460708 DOI: 10.1016/j.lfs.2022.120563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bosma KJ, Kaiser CE, Kimple ME, Gannon M. Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass. Metabolites 2022;12:342. [DOI: 10.3390/metabo12040342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nichols CG, York NW, Remedi MS. ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm? Diabetes 2022;71:367-75. [PMID: 35196393 DOI: 10.2337/db21-0755] [Reference Citation Analysis]
8 Davies A, Tomas A. Appreciating the potential for GPCR crosstalk with ion channels. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.06.013] [Reference Citation Analysis]
9 Murao N, Yokoi N, Takahashi H, Hayami T, Minami Y, Seino S. Increased glycolysis affects β-cell function and identity in aging and diabetes. Mol Metab 2021;55:101414. [PMID: 34871777 DOI: 10.1016/j.molmet.2021.101414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Lin H, Smith N, Spigelman AF, Suzuki K, Ferdaoussi M, Alghamdi TA, Lewandowski SL, Jin Y, Bautista A, Wang YW, Manning Fox JE, Merrins MJ, Buteau J, MacDonald PE. β-Cell Knockout of SENP1 Reduces Responses to Incretins and Worsens Oral Glucose Tolerance in High-Fat Diet-Fed Mice. Diabetes 2021;70:2626-38. [PMID: 34462260 DOI: 10.2337/db20-1235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
11 Costes S, Bertrand G, Ravier MA. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies. Int J Mol Sci 2021;22:5303. [PMID: 34069914 DOI: 10.3390/ijms22105303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
12 Marzook A, Tomas A, Jones B. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells. Front Endocrinol (Lausanne) 2021;12:678055. [PMID: 34040588 DOI: 10.3389/fendo.2021.678055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
13 Hussain MA, Laimon-Thomson E, Mustafa SM, Deck A, Song B. Detour Ahead: Incretin Hormone Signaling Alters Its Intracellular Path as β-Cell Failure Progresses During Diabetes. Front Endocrinol (Lausanne) 2021;12:665345. [PMID: 33935974 DOI: 10.3389/fendo.2021.665345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang W, Sakoda H, Nakazato Y, Islam MN, Pattou F, Kerr-Conte J, Nakazato M. Neuromedin U uses Gαi2 and Gαo to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic β cells. PLoS One 2021;16:e0250232. [PMID: 33857254 DOI: 10.1371/journal.pone.0250232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Horita S, Ono T, Gonzalez-Resines S, Ono Y, Yamachi M, Zhao S, Domene C, Maejima Y, Shimomura K. Structure based analysis of KATP channel with a DEND syndrome mutation in murine skeletal muscle. Sci Rep 2021;11:6668. [PMID: 33758250 DOI: 10.1038/s41598-021-86121-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Nichols CG, York NW, Remedi MS. Preferential Gq signaling in diabetes: an electrical switch in incretin action and in diabetes progression? J Clin Invest 2020;130:6235-7. [PMID: 33196460 DOI: 10.1172/JCI143199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ. Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation. Endocr Rev 2021;42:101-32. [PMID: 33320179 DOI: 10.1210/endrev/bnaa032] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 23.5] [Reference Citation Analysis]
18 Lin H, Smith N, Spigelman AF, Suzuki K, Ferdaoussi M, Jin Y, Bautista A, Wang YW, Fox JEM, Buteau J, Macdonald PE. β-cell SENP1 facilitates responsiveness to incretins and limits oral glucose intolerance in high fat fed mice.. [DOI: 10.1101/2020.11.30.402644] [Reference Citation Analysis]